The Coalition for Innovation in Preparing for the Epidemic (CEPI), the Alliance for Gifts and the World Health Organization (OMS), together with UNICEF, published the first provisional provision of COVAX provisional, the Equitable distribution of vacancies at world level. According to preliminary figures, it was estimated to reach 337.2 million over the first half of the year.
The document recounts the distribution of at least 240 million doses of the AstraZeneca / Oxford vaccine, which will be produced by the Serum Institute of India, and 96 million doses of this vaccine vaccine in virtue of the agreement reached between Gavi and AstraZeneca for the first and second quarters of 2021. As a result, a total of 336 million doses will be distributed in the first six months of this year to the 145 countries that form part of COVAX, while the OMS always has the authority as emergency.
In view of Pfizer’s bionex on BioNTech, approved by the OMS on the Emergency Usage List, COVAX currently predicts that 1.2 million doses of this ammunition will be available in the first quarter of 2021, only “subject to finalization of additional agreements “. As part of the second quarter, the 92 countries will face “additional volumes”, following the agreement reached between an early firm between Gavi and Pfizer-BioNTech for a maximum of 40 million doses.
“The objective of sharing the provisional distribution with the countries, including the current World Economic Summit of Dynamic, is to provide the governing bodies and the sanitary systems with the information necessary to plan their national evacuation programs.” Gavi’s CEO Seth Berkley explained in a press release that the total price of the operation “will be published at the earliest possible time”.
As a result, the COVAX meta, according to Berkley, sums up 2,300 million doses in annual finals, of which 1,800 million are destined to pay low rent without any expense to their governors.
This provisional provisional provision describes the provisioning of the dose of vacancies to all participants in COVAX, with the exception of the participants who owned the right of exclusion, who did not present vacancies of vacancies or those to whom he assigned dosage.
In addition to the “dose limitation, the conditions associated with the delivery of a vaccine that require an ultra-free range and to guarantee the maximum impact on public health”, COVAX officials have taken the decision to limit the number of pays to the first entrances of the Pfizer-BioNTech vacancy with the end of allowing a distribution and integration satisfactory.
At the moment, the total dose covers, by the medium term, the 3.3 per cent of the total population of 145 participants. “It is in agreement with the objective of COVAX to increase by at least 3 per cent the population coverage in all areas during the first semester of this year, sufficient to protect the most vulnerable groups, such as health workers”, ha añadido Berkley.
35 million doses for Latin America
There are 36 countries and territories in Latin America receiving more than 35 million doses of COVID-19 vaccine from the COVAX initiative, which could be recovered from the second half of February and the second quarter of 2021.
Four Latin American countries, Bolivia, Colombia, El Salvador and Peru, have been selected for the ‘Primera Ola’ pilot program and received 378,000 doses of Pfizer vehicles in mid-February.
Specifically, the following countries: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belice, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominica, Ecuador, El Salvador, San Cristóbal y Nieves, Granada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Dominican Republic, San Vicente and Granadinas, Santa Lucia, Suriname, Trinidad and Tabago, Uruguay and Venezuela.
In the wake of this month, Bruce Aylward, senior assessor of the OMS, recorded as a projection basadas in the estimates of the pharmaceutical. “There are a lot of advertisements and considerations, because the producers can have lower volumes than the aspirant, you can have retrospectives on the use of emergency and you can change”, he said.
“We hope to see the real projections of dose doses in February and March, because we have seen that there are some technical problems in the manufacture of the vacancies at this time and can have less to distribute”, added the subdirector of Sim